Co-Diagnostics, Inc. (CODX)
4.71
-0.17
(-3.48%)
USD |
NASDAQ |
Jun 11, 14:43
Co-Diagnostics Total Liabilities (Quarterly) : 5.457M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 5.457M |
| December 31, 2025 | 6.488M |
| September 30, 2025 | 4.912M |
| June 30, 2025 | 5.327M |
| March 31, 2025 | 7.228M |
| December 31, 2024 | 16.88M |
| September 30, 2024 | 8.597M |
| June 30, 2024 | 8.304M |
| March 31, 2024 | 8.318M |
| December 31, 2023 | 17.63M |
| September 30, 2023 | 9.192M |
| June 30, 2023 | 9.369M |
| March 31, 2023 | 6.367M |
| December 31, 2022 | 13.71M |
| September 30, 2022 | 12.90M |
| June 30, 2022 | 16.37M |
| March 31, 2022 | 23.44M |
| December 31, 2021 | 26.12M |
| September 30, 2021 | 5.200M |
| June 30, 2021 | 5.524M |
| March 31, 2021 | 4.862M |
| Date | Value |
|---|---|
| December 31, 2020 | 4.541M |
| September 30, 2020 | 1.874M |
| June 30, 2020 | 3.065M |
| March 31, 2020 | 1.313M |
| December 31, 2019 | 0.4781M |
| September 30, 2019 | 0.4779M |
| June 30, 2019 | 0.5121M |
| March 31, 2019 | 0.5575M |
| December 31, 2018 | 2.612M |
| September 30, 2018 | 2.586M |
| June 30, 2018 | 0.7263M |
| March 31, 2018 | 0.7618M |
| December 31, 2017 | 0.8118M |
| September 30, 2017 | 0.8632M |
| June 30, 2017 | 4.863M |
| March 31, 2017 | 4.481M |
| December 31, 2016 | 4.290M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 1.518M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Fractyl Health, Inc. | 78.01M |
| Spectral AI, Inc. | 26.54M |
| Sangamo Therapeutics, Inc. | 78.92M |
| INmune Bio, Inc. | 6.194M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.50M |
| Shareholders Equity (Quarterly) | 16.04M |
| Debt to Equity Ratio | 0.1266 |
| Current Ratio | 2.283 |
| Net Debt Paydown Yield | 0.36% |